Air Tamponade in Macular Hole Surgery
1 other identifier
interventional
20
1 country
1
Brief Summary
Macular hole is a hole formation which takes place in the center of the retina. Such a hole needs surgical steps in order to close. Closure of the macular hole will lead to a substantially improvement of vision in most cases. Following macular hole surgery a tamponade of intraocular gas is normally injected in order to keep the macula dry for the postoperative period. Postoperative face down position for a week was earlier standard. Several authors report of good closure rates with both air tamponade or lack of face down positioning. In this study standard pars plana vitrectomy with peeling of the internal limiting membrane (ILM) will be performed. The gas tamponade will be replaced by air. Postoperative face down positioning will not be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 3, 2012
CompletedFirst Posted
Study publicly available on registry
September 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedDecember 6, 2013
December 1, 2013
1.1 years
September 3, 2012
December 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Closure rate of macular hole
1 month after enrollment
Secondary Outcomes (1)
Closure rate in macular holes larger than 400 micrometer
1 month after enrollment
Other Outcomes (1)
Visual gain after 6 months of follow up
6 months after enrollment
Study Arms (1)
Pars plana vitrectomy and postoperative air tamponade
EXPERIMENTALPars plana vitrectomy, ILM peeling and air tamponade. No postoperative face down positioning. All patients need to be pseudophakic prior to intervention.
Interventions
Pars plans vitrectomy, ILM peeling and air tamponade. No postoperative face down positioning. All patients need to be pseudophakic prior to intervention.
Eligibility Criteria
You may qualify if:
- Idiopathic stage 2 - 4 macular hole
- Duration of symptoms ≤ 36 months
- Informed consent
You may not qualify if:
- Previous vitreomacular surgery
- Myopia ≥ 6 diopters
- Ocular trauma
- Disease affecting visual function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helse Stavanger HFlead
- Haukeland University Hospitalcollaborator
Study Sites (1)
Stavanger University Hospital, Department of Ophthalmology
Stavanger, 4016, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Vegard Forsaa, MD
Helse Stavanger HF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2012
First Posted
September 6, 2012
Study Start
September 1, 2012
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
December 6, 2013
Record last verified: 2013-12